Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lumos Pharma Inc.

    NASDAQ: LUMO · Real-Time Price · USD
    4.34
    0.00 (0.00%)
    At close: Dec 11, 2024, 10:00 PM

    Lumos Pharma Statistics

    Share Statistics

    Lumos Pharma has 8.65M shares outstanding. The number of shares has increased by 6.56% in one year.

    Shares Outstanding

    n/a
    		 8.65M

    Shares Change (YoY)

    n/a
    		 6.56%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 25.08%

    Shares Floating

    n/a
    		 5.66M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,448

    FTD / Avg. Volume

    n/a
    		 2.38%

    Short Selling Information

    The latest short interest is 54.33K, so 0.63% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 54.33K

    Short % of Shares Out

    n/a
    		 0.63%

    Short % of Float

    n/a
    		 0.87%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.76 and the forward PE ratio is null. Lumos Pharma's PEG ratio is -0.06.

    PE Ratio

    n/a
    		 -0.76

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 12.63

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.95

    P/FCF Ratio

    n/a
    		 -0.83

    PEG Ratio

    n/a
    		 -0.06
    Financial Ratio History

    Enterprise Valuation

    Lumos Pharma has an Enterprise Value (EV) of -8.59M.

    EV / Sales

    n/a
    		 -4.19

    EV / EBITDA

    n/a
    		 0.23

    EV / EBIT

    n/a
    		 0.28

    EV / FCF

    n/a
    		 0.28

    Financial Position

    The company has a current ratio of 5.69, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 5.69

    Quick Ratio

    n/a
    		 5.69

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -124.64% and Return on Invested Capital is -132.61%.

    Return on Equity

    n/a
    		 -124.64%

    Return on Assets

    n/a
    		 -83.75%

    Return on Invested Capital

    n/a
    		 -132.61%

    Revenue Per Employee

    n/a
    		 $68,366.67

    Profits Per Employee

    n/a
    		 $-1,134,466.67

    Employee Count

    n/a
    		 30

    Asset Turnover

    n/a
    		 0.05

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -29K

    Effective Tax Rate

    n/a
    		 0.09%

    Stock Price Statistics

    The stock price has increased by 55% in the last 52 weeks. The beta is 0.33, so Lumos Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.33

    52-Week Price Change

    n/a
    		 55%

    50-Day Moving Average

    n/a
    		 4.22

    200-Day Moving Average

    n/a
    		 3.1

    Relative Strength Index (RSI)

    n/a
    		 55.58

    Average Volume (20 Days)

    n/a
    		 102,979

    Income Statement

    In the last 12 months, Lumos Pharma had revenue of 2.05M and earned -34.03M in profits. Earnings per share was -4.18.

    Revenue

    n/a
    		 2.05M

    Gross Profit

    n/a
    		 2.05M

    Operating Income

    n/a
    		 -36.61M

    Net Income

    n/a
    		 -34.03M

    EBITDA

    n/a
    		 -36.57M

    EBIT

    n/a
    		 -36.61M

    Earnings Per Share (EPS)

    n/a
    		 -4.18
    Full Income Statement

    Balance Sheet

    The company has 35.08M in cash and 585K in debt, giving a net cash position of 34.49M.

    Cash & Cash Equivalents

    n/a
    		 35.08M

    Total Debt

    n/a
    		 585K

    Net Cash

    n/a
    		 34.49M

    Retained Earnings

    n/a
    		 -161.52M

    Total Assets

    n/a
    		 17.46M

    Working Capital

    n/a
    		 10.77M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -31.09M and capital expenditures 0, giving a free cash flow of -31.09M.

    Operating Cash Flow

    n/a
    		 -31.09M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -31.09M

    FCF Per Share

    n/a
    		 -3.82
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -1785.18% and -1659.39%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -1785.18%

    Pretax Margin

    n/a
    		 -1660.8%

    Profit Margin

    n/a
    		 -1659.39%

    EBITDA Margin

    n/a
    		 -1783.03%

    EBIT Margin

    n/a
    		 -1785.18%

    FCF Margin

    n/a
    		 -1516.09%

    Dividends & Yields

    LUMO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -131.4%

    FCF Yield

    n/a
    		 -120.05%
    Dividend Details

    Analyst Forecast

    The average price target for LUMO is $8.62, which is 98.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $8.62

    Price Target Difference

    n/a
    		 98.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 19, 2020. It was a backward split with a ratio of 1:9.

    Last Split Date

    n/a
    		 Mar 19, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:9

    Scores

    Altman Z-Score

    n/a
    		 -19.2

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist